학술논문
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models
Document Type
Article
Author
Source
In: Cancers . (Cancers, February 2023, 15(3))
Subject
Language
English
ISSN
20726694